Ilyang Pharmaceutical Co Ltd (007575) — Long-term Investment Intensity
Ilyang Pharmaceutical Co Ltd (007575) has a Long-term Investment Intensity of 0.8% as of December 2019. Long-term investments of ₩3.36 Billion represent 0.8% of total assets of ₩437.46 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Ilyang Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ilyang Pharmaceutical Co Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Ilyang Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 0.8%, reflecting long-term investments of ₩3.36 Billion against total assets of ₩437.46 Billion KRW. Explore Ilyang Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Ilyang Pharmaceutical Co Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Ilyang Pharmaceutical Co Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 007575 stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.8% | ₩3.36 Billion | ₩437.46 Billion | ▼ -0.3 pp |
| 2018 | 1.0% | ₩4.47 Billion | ₩432.25 Billion | ▼ -0.1 pp |
| 2017 | 1.2% | ₩5.11 Billion | ₩436.37 Billion | ▲ +0.1 pp |
| 2016 | 1.1% | ₩4.56 Billion | ₩431.26 Billion | ▲ +0.2 pp |
| 2015 | 0.9% | ₩3.72 Billion | ₩431.63 Billion | ▲ +0.1 pp |
| 2014 | 0.8% | ₩3.44 Billion | ₩430.83 Billion | — |